Prospective, multi-centre, non-interventional safety study to collect real-world data on the safety of immunotherapy with Depigoid® Katze in patients with allergic rhinitis/rhino-conjunctivitis with or without controlled asthma due to feline epithelia (LETI MIAU-KAT 2022)

First published 04/03/2022

Last updated 22/05/2025

EU PAS number:

EUPAS46091

Study

Finalised

Documents

Study protocol

Study results

1.3 List of Data tables.pdf

English (377.29 KB - PDF)View document

Study report

LETI MIAU-KAT_CSR_20250331_redacted.pdf

English (1.66 MB - PDF)View document

LETI MIAU-KAT_CSR_final_20250508_redacted.pdf

English (5.75 MB - PDF)View document

Other information

Study, other information

1.1 List of AE-Symptoms.pdf

English (227.56 KB - PDF)View document

1.2 List of participating investigators.pdf

English (53.46 KB - PDF)View document

1.4 Federal state specific ICF versions.pdf

English (89.97 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs